Skip to main content
. 2018 Nov;56:29–38. doi: 10.1016/j.biologicals.2018.09.001

Table 1.

Characterisation of samples used in this study.

Study code NIBSC code Description Reactivity in the VaccZyme ELISA
16/138 Pooled Anti-Vi IgG sera from 16 volunteers 631 U mL−1a
Vi-IgGR1, 2011 Purified Anti-Vi IgG from 5 volunteers 1280 U mL−1b
A 10/126 Pooled Anti-Vi IgG sera from 9 volunteers 842 U mL−1c
B 16/150 Post-Typbar TCV vaccination serum 350 U mL−1c
C 16/138 Pooled Anti-Vi IgG sera from 16 volunteers 631 U mL−1a
D 16/144 Post-Vi PS vaccination serum 345 U mL−1c
E 16/146 Post-Vi PS vaccination serum 524 U mL−1c
F 16/140 Pre-Vaccination serum 22 U mL−1c
a

Based on an estimate from 3 runs.

b

Based on an estimate from 4 runs.

c

Based on an estimate from one run.